The two-compartment minimal model (2CMM) interpretation of a labeled intravenous glucose tolerance test (IVGTT) is a powerful tool to assess glucose metabolism in a single individual. It has been reported that a derived 2CMM parameter describing the proportional effect of glucose on insulin-independent glucose disposal can take physiologically unplausible negative values. In addition, precision of 2CMM parameter estimates is sometimes not satisfactory. Here we resolve the above issues by presenting an improved version of 2CMM that relies on a new assumption on the constant component R d0 of insulin-independent glucose disposal. Here R d0 is not fixed to 1 mg ⅐ kg Ϫ1 ⅐ min Ϫ1 but instead is expressed as a fraction of steady-state glucose disposal. The new 2CMM is identified on the same stable labeled IVGTT data base on which the original 2CMM was formulated. A more reliable insulin-independent glucose disposal portrait is obtained while that of insulin action remains unchanged. The new 2CMM also improves the precision with which model parameters and metabolic indexes are estimated. insulin sensitivity; glucose effectiveness; glucose production; mathematical model; parameter estimation; intravenous glucose tolerance test THE TWO-COMPARTMENT MINIMAL MODEL (2CMM) interpretation of the labeled intravenous glucose tolerance test (IVGTT) is a powerful tool to assess glucose metabolism in a single individual, since it allows characterization of glucose disposal in terms of indexes of insulin sensitivity and glucose effectiveness (10) and reconstruction of the time course of endogenous glucose production (3, 11). The model has been employed and is currently being used in several studies (e.g., Refs. 5 and 7-9). One parameter that can be calculated from the estimated model parameters is the proportional effect of glucose on insulin-independent glucose disposal, denoted as k p (min Ϫ1 ). We and other investigators (personal communication) have observed that sometimes k p can take on negative values, a physically unrealizable event. For instance, Vicini et al. (10) noted that this happens in 3 of the 14 subjects studied.
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Another reported finding is that sometimes the precision of the parameter estimates of 2CMM is not satisfactory.
This brief contribution aims at resolving the above issues by an improved version of 2CMM. In particular, we first outline the conditions under which parameter k p can take on positive values by reconsidering the assumptions underlying the model. Next, we formulate an improved version of the model that guarantees positive values of all parameters. Results on the same 14 subjects studied previously (10) are presented and compared with those obtained with the previous version of the model.
THE TWO-COMPARTMENT MINIMAL MODEL
The 2CMM (Fig. 1) is described by the following equations
where q 1 (t) and q 2 (t) denote tracer glucose masses at time t in the first (accessible) and second (slowly equilibrating) compartments, respectively (mg/kg for a stable-label IVGTT); x(t) ϭ k c IЈ(t) is insulin action (min Ϫ1 ), where IЈ(t) is the concentration of insulin remote from plasma (U/ml); I(t) and I b are plasma insulin and basal (end-test) insulin, respectively (U/ml); Q 1 (t) is total glucose mass in the accessible pool (mg/kg); g(t) is plasma tracer glucose concentration (mg/dl); d is the tracer glucose dose (mg/kg); V 1 is the volume of the accessible pool (ml/kg); R d0 (mg ⅐ kg Ϫ1 ⅐ min Ϫ1 ) is the constant component of glucose disposal, whereas k p (min
Ϫ1
) is the proportionality constant between glucose disposal from the accessible compartment and glucose mass in the same compartment; k 21 (min Ϫ1 ), k 12 (min Ϫ1 ), and k 02 (min Ϫ1 ) are parameters describing glucose kinetics; and p 2 ϭ k b (min Ϫ1 ) and
) are parameters describing insulin action. Capital and lowercase letters are used to denote variables related to cold and tracer glucose, respectively, and overdot notation refers to time rates of change for respective variables.
The model assumes that pools 1 and 2 represent, respectively, plasma plus insulin-independent tissues, rapidly equilibrating with plasma, and insulin-dependent tissues (utilization depends on insulin in addition to glucose), slowly exchanging with plasma. Glucose disposal from the accessible pool, R d1 , is the sum of two components, one constant (R d0 ) and the other (k p Q 1 ) proportional to glucose mass Q 1 , thus accounting for the inhibition of glucose clearance by glucose itself. Thus the rate constant describing the irreversible loss of both tracer and tracee from the accessible pool is
where r d1 is insulin-independent tracer glucose disposal and G 1 is the glucose concentration in the accessible pool of volume V 1 . Glucose disposal from the slowly exchanging pool is assumed to be parametrically controlled by insulin in a remote compartment represented by variable x. The rate constant describing irreversible loss of tracee and tracer from compartment 2, R d2 and r d2 , respectively, is then
Arriving at a priori unique identifiability requires two assumptions (3). First, in normal subjects in the basal steady state (ss), insulin-independent glucose disposal is three times glucose disposal from insulin-dependent tissues (R d1 ss ϭ 3R d2 ss ; see Refs. 4 and 6). This materializes in an additional relationship among the model parameters
where G b is basal (evaluated from end test values) glucose concentration (mg/dl). Moreover, R d0 is fixed to the experimentally determined value of 1 mg ⅐ kg Ϫ1 ⅐ min
. The 2CMM allows the estimation of glucose effectiveness, insulin sensitivity, and plasma clearance rate.
Glucose Effectiveness
Glucose effectiveness (S G 2 *; ml⅐ kg Ϫ1 ⅐ min
Ϫ1
) quantifies the ability of glucose to promote its own disposal at steady state
Plasma Clearance Rate
Plasma clearance rate (PCR; ml ⅐ kg Ϫ1 ⅐ min Ϫ1 ) measures glucose disposal at basal steady state, per unit glucose concentration (6) where the last equality follows from Eq. 4. 
Insulin Sensitivity
Insulin sensitivity (S I 2 *; ml⅐ kg Ϫ1 ⅐ min Ϫ1 per U/ml) quantifies the ability of insulin to enhance glucose effectiveness
MODEL ASSUMPTIONS AND PARAMETER KP
Model assumptions do not guarantee positive values for parameter k p in all circumstances. In fact, from Eq. 4, k p is the difference between the following two terms
and assumes positive values only when
that is, from Eq. 6, when
Thus k p is positive if the constant component R d 0 , which is fixed equal to 1 mg ⅐ min Ϫ1 ⅐ kg Ϫ1 in all subjects, is less than the steady-state value of glucose disposal from the accessible compartment, which accounts for three-fourths of total glucose disposal. This condition can also be read as a lower bound for total glucose disposal at steady state
The assumption of a constant component of glucose disposal equal to 1 mg ⅐ min Ϫ1 ⅐ kg Ϫ1 is thus critical because it leads to a negative value of the k p parameter in those subjects having a total glucose disposal in the basal state Ͻ1.33 mg ⅐ min Ϫ1 ⅐ kg
Ϫ1
.
AN IMPROVED 2CMM
To ensure positive values of k p , we formulate the needed (for a priori identifiability reasons) constraint on R d0 in an alternative way. The idea is to relate it to total glucose disposal in steady state, by assuming that R d0 accounts for a fixed fraction of it , PCR, and S I 2* are still defined as before and can be evaluated from model parameters by using the same expressions (Eqs. 5-7).
MODEL IDENTIFICATION
The new 2CMM equations to be used in normal subjects are Eqs. 1a-1d, coupled with Eq. 14 for parameter k p appearing in Eq. 1a and with the following equation, derived from Eqs. 6 and 12, for R d0 /Q 1 (t), also appearing in Eq. 1a
Unknown model parameters k 21 , k 12 , k 02 , s k , p 2 , and V 1 were estimated in each individual by using SAAMII software (1) . Weights were chosen as described previously (10) .
RESULTS
In a previous study (10) , the 2CMM was identified on stable labeled IVGTT data performed in 14 young Values are means Ϯ SE. 2CMM, two-compartment minimal model; V1, volume of the accessible pool; k21; k12, and k02, glucose kinetic parameters; p2, and sk, parameters describing insulin action S G 2* , glucose effectiveness; S I 2* , insulin sensitivity. PCR, plasma clearance rate. Precision of parameter estimates shown as mean coefficient of variation is in parentheses. * Statistically different from original 2CMM (Wilcoxon test, P Ͻ 0.05).
adults. For the individual parameter estimates and metabolic indexes, we refer to Tables 1 and 2 (Table 2) . In three subjects, R d ss is Ͻ1.33 and k p is negative, in keeping with the considerations developed above.
The improved version of 2CMM was then identified on the same data set. Its ability to describe the data is virtually the same as that of the original 2CMM, i.e., since the plots of their average residuals are virtually superimposable (data not shown).
Average values of its model parameters and metabolic indexes (Table 1 (Table 2) is now positive in all subjects.
The improved 2CMM also has a better performance in terms of precision of parameter estimates, since the coefficients of variation are markedly lower for all parameters (Table 1) .
DISCUSSION
We have presented a new version of 2CMM that guarantees positive values of the derived parameter k p in all individuals. This goal is accomplished by introducing a different, but still physiologically sound, assumption on R d0 . R d0 is a nonphysiological parameter that represents the nonzero intercept of the linear approximation, in the experimental glucose range, of the relationship between insulin-independent glucose disposal and glucose concentration.
In all likelihood, this relationship is a sigmoidalshaped curve that, starting at zero (glucose utilization is 0 at 0 glucose concentration), saturates at a plateau. It is also often described by a MichaelisMenten relationship, but the range of glucose concentrations spanned during an IVGTT does not allow for reliable estimation of the two parameters of this model. The relationship is then approximated by a straight line, having k p as a slope and R d0 as an intercept. In the new version, R d0 is adjusted in every subject on the basis of his/her value of total glucose disposal in the basal state, R d0 ϭ ␣R d ss ϭ 0.78 Ϯ 0.6 mg ⅐ min Ϫ1 ⅐ kg Ϫ1 , which is less than the value R d0 ϭ 1 mg ⅐ min Ϫ1 ⅐ kg Ϫ1 assumed in the original version. The decrease in R d0 is balanced by an increase in the glucose-dependent component of glucose disposal, and thus by an increase of k p and S G 2* , because their sum, which gives insulin-independent glucose disposal, is similar in the two model versions. All of the remaining model indexes are also similar. It is not possible to prove that the new model provides more accurate estimates of S G 2* , since we do not have a model-independent reference for it. However, we can argue that, because the new 2CMM avoids some inconsistencies of the original 2CMM (negative k p ), it provides a more reliable description of the system and thus a more reliable value for S G 2* . Similarly, we can also argue that the new model should provide more reliable estimates of endogenous glucose production. Finally, with the new assumption, precision of parameter estimates considerably improves.
The 2CMM, developed here for application in normal subjects, can be extended to impaired glucose-tolerant or diabetic subjects. This, however, requires reconsideration of some model assumptions, as discussed in the APPENDIX. In conclusion, this improved version of 2CMM, by avoiding some inconsistencies of the original 2CMM (negative k p ), provides a more reliable and precise parametric portrait of glucose metabolism during an IVGTT.
